CLBAX
Price
$34.71
Change
+$0.22 (+0.64%)
Updated
Dec 24 closing price
RLBFX
Price
$34.84
Change
+$0.22 (+0.64%)
Updated
Dec 24 closing price
Ad is loading...

CLBAX vs RLBFX

Header iconCLBAX vs RLBFX Comparison
Open Charts CLBAX vs RLBFXBanner chart's image
American Funds American Balanced 529A
Price$34.71
Change+$0.22 (+0.64%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5
Price$34.84
Change+$0.22 (+0.64%)
VolumeN/A
CapitalizationN/A
CLBAX vs RLBFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CLBAX vs. RLBFX commentary
Dec 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBAX is a Buy and RLBFX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CLBAX (239B) and RLBFX (239B) have equal amount of cash in the bank . RLBFX pays higher dividends than CLBAX: RLBFX (2.50) vs CLBAX (2.23). CLBAX was incepted earlier than RLBFX: CLBAX (23 years) vs RLBFX (23 years). CLBAX (171.00) and RLBFX (171.00) have comparable annual turnover. CLBAX (250) and RLBFX (250) have matching initial minimum investment requirements. RLBFX (11.76) and CLBAX (11.41) have marching annual gain over last year. CLBAX (32.72) and RLBFX (32.69) have equivalent 5 years return.
CLBAXRLBFXCLBAX / RLBFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years23 years-
Gain YTD10.92011.27297%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets239B239B100%
Annual Yield % from dividends2.232.5089%
Returns for 1 year11.4111.7697%
Returns for 3 years11.1810.50106%
Returns for 5 years32.7232.69100%
Returns for 10 years65.7655.58118%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AWH0.770.02
+3.11%
Aspira Women's Health
FWRG19.280.40
+2.12%
First Watch Restaurant Group
PEG85.790.56
+0.66%
Public Service Enterprise Group
TXG14.67-0.06
-0.41%
10x Genomics
LXRX0.76-0.07
-8.37%
Lexicon Pharmaceuticals